Page last updated: 2024-09-03

sr 48692 and Glial Cell Tumors

sr 48692 has been researched along with Glial Cell Tumors in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cui, H; Dai, Y; Feng, H; Gong, X; Ouyang, Q; Xiao, H; Xu, L; Xu, M; Yi, L; Zhou, J	1

Other Studies

1 other study(ies) available for sr 48692 and Glial Cell Tumors

Article	Year
Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients. Molecular cancer, 2015, Feb-03, Volume: 14 Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Gene Expression Regulation, Neoplastic; Glioma; Humans; Mice; Neoplasm Invasiveness; Neurotensin; Phosphorylation; Prognosis; Protein Precursors; Pyrazoles; Quinolines; Receptors, Neurotensin	2015

Article

Year

Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients.

Molecular cancer, 2015, Feb-03, Volume: 14

Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Gene Expression Regulation, Neoplastic; Glioma; Humans; Mice; Neoplasm Invasiveness; Neurotensin; Phosphorylation; Prognosis; Protein Precursors; Pyrazoles; Quinolines; Receptors, Neurotensin

2015